GLOBAL PROTEIN DEGRADATION THERAPY MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Sep 2021 73
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Protein Degradation Therapy
1.2 Classification of Protein Degradation Therapy by Type
1.2.1 Overview: Global Protein Degradation Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Protein Degradation Therapy Revenue Market Share by Type in 2020
1.2.3 ARV-110
1.2.4 ARV-471
1.2.5 Other
1.3 Global Protein Degradation Therapy Market by Application
1.3.1 Overview: Global Protein Degradation Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Neuroscience
1.3.4 Other
1.4 Global Protein Degradation Therapy Market Size & Forecast
1.5 Global Protein Degradation Therapy Market Size and Forecast by Region
1.5.1 Global Protein Degradation Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Protein Degradation Therapy Market Size by Region, (2016-2021)
1.5.3 North America Protein Degradation Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Protein Degradation Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Protein Degradation Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Protein Degradation Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Protein Degradation Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Protein Degradation Therapy Market Drivers
1.6.2 Protein Degradation Therapy Market Restraints
1.6.3 Protein Degradation Therapy Trends Analysis
2 Company Profiles
2.1 Arvinas
2.1.1 Arvinas Details
2.1.2 Arvinas Major Business
2.1.3 Arvinas Protein Degradation Therapy Product and Solutions
2.1.4 Arvinas Protein Degradation Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Arvinas Recent Developments and Future Plans
2.2 Nurix Therapeutics
2.2.1 Nurix Therapeutics Details
2.2.2 Nurix Therapeutics Major Business
2.2.3 Nurix Therapeutics Protein Degradation Therapy Product and Solutions
2.2.4 Nurix Therapeutics Protein Degradation Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Nurix Therapeutics Recent Developments and Future Plans
2.3 Kymera Therapeutics
2.3.1 Kymera Therapeutics Details
2.3.2 Kymera Therapeutics Major Business
2.3.3 Kymera Therapeutics Protein Degradation Therapy Product and Solutions
2.3.4 Kymera Therapeutics Protein Degradation Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Kymera Therapeutics Recent Developments and Future Plans
2.4 C4 Therapeutics
2.4.1 C4 Therapeutics Details
2.4.2 C4 Therapeutics Major Business
2.4.3 C4 Therapeutics Protein Degradation Therapy Product and Solutions
2.4.4 C4 Therapeutics Protein Degradation Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 C4 Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Protein Degradation Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Protein Degradation Therapy Players Market Share
3.2.2 Top 10 Protein Degradation Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Protein Degradation Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Protein Degradation Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Protein Degradation Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Protein Degradation Therapy Revenue Market Share by Application (2016-2021)
5.2 Protein Degradation Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Protein Degradation Therapy Revenue by Type (2016-2026)
6.2 North America Protein Degradation Therapy Revenue by Application (2016-2026)
6.3 North America Protein Degradation Therapy Market Size by Country
6.3.1 North America Protein Degradation Therapy Revenue by Country (2016-2026)
6.3.2 United States Protein Degradation Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Protein Degradation Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Protein Degradation Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Protein Degradation Therapy Revenue by Type (2016-2026)
7.2 Europe Protein Degradation Therapy Revenue by Application (2016-2026)
7.3 Europe Protein Degradation Therapy Market Size by Country
7.3.1 Europe Protein Degradation Therapy Revenue by Country (2016-2026)
7.3.2 Germany Protein Degradation Therapy Market Size and Forecast (2016-2026)
7.3.3 France Protein Degradation Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Protein Degradation Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Protein Degradation Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Protein Degradation Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Protein Degradation Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Protein Degradation Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Protein Degradation Therapy Market Size by Region
8.3.1 Asia-Pacific Protein Degradation Therapy Revenue by Region (2016-2026)
8.3.2 China Protein Degradation Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Protein Degradation Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Protein Degradation Therapy Market Size and Forecast (2016-2026)
8.3.5 India Protein Degradation Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Protein Degradation Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Protein Degradation Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Protein Degradation Therapy Revenue by Type (2016-2026)
9.2 South America Protein Degradation Therapy Revenue by Application (2016-2026)
9.3 South America Protein Degradation Therapy Market Size by Country
9.3.1 South America Protein Degradation Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Protein Degradation Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Protein Degradation Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Protein Degradation Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Protein Degradation Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Protein Degradation Therapy Market Size by Country
10.3.1 Middle East & Africa Protein Degradation Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Protein Degradation Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Protein Degradation Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Protein Degradation Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Protein Degradation Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Protein Degradation Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Protein Degradation Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Protein Degradation Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Protein Degradation Therapy Revenue Market Share by Region (2021-2026)
Table 6. Arvinas Corporate Information, Head Office, and Major Competitors
Table 7. Arvinas Major Business
Table 8. Arvinas Protein Degradation Therapy Product and Solutions
Table 9. Arvinas Protein Degradation Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Nurix Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Nurix Therapeutics Major Business
Table 12. Nurix Therapeutics Protein Degradation Therapy Product and Solutions
Table 13. Nurix Therapeutics Protein Degradation Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Kymera Therapeutics Corporate Information, Head Office, and Major Competitors
Table 15. Kymera Therapeutics Major Business
Table 16. Kymera Therapeutics Protein Degradation Therapy Product and Solutions
Table 17. Kymera Therapeutics Protein Degradation Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. C4 Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. C4 Therapeutics Major Business
Table 20. C4 Therapeutics Protein Degradation Therapy Product and Solutions
Table 21. C4 Therapeutics Protein Degradation Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Protein Degradation Therapy Revenue (USD Million) by Players (2019-2021)
Table 23. Global Protein Degradation Therapy Revenue Share by Players (2019-2021)
Table 24. Breakdown of Protein Degradation Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Protein Degradation Therapy Players Head Office, Products and Services Provided
Table 26. Protein Degradation Therapy Mergers & Acquisitions in the Past Five Years
Table 27. Protein Degradation Therapy New Entrants and Expansion Plans
Table 28. Global Protein Degradation Therapy Revenue (USD Million) by Type (2016-2021)
Table 29. Global Protein Degradation Therapy Revenue Share by Type (2016-2021)
Table 30. Global Protein Degradation Therapy Revenue Forecast by Type (2021-2026)
Table 31. Global Protein Degradation Therapy Revenue by Application (2016-2021)
Table 32. Global Protein Degradation Therapy Revenue Forecast by Application (2021-2026)
Table 33. North America Protein Degradation Therapy Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Protein Degradation Therapy Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Protein Degradation Therapy Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Protein Degradation Therapy Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Protein Degradation Therapy Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Protein Degradation Therapy Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Protein Degradation Therapy Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Protein Degradation Therapy Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Protein Degradation Therapy Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Protein Degradation Therapy Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Protein Degradation Therapy Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Protein Degradation Therapy Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Protein Degradation Therapy Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Protein Degradation Therapy Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Protein Degradation Therapy Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Protein Degradation Therapy Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Protein Degradation Therapy Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Protein Degradation Therapy Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Protein Degradation Therapy Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Protein Degradation Therapy Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Protein Degradation Therapy Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Protein Degradation Therapy Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Protein Degradation Therapy Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Protein Degradation Therapy Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Protein Degradation Therapy Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Protein Degradation Therapy Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Protein Degradation Therapy Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Protein Degradation Therapy Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Protein Degradation Therapy Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Protein Degradation Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Protein Degradation Therapy Picture
Figure 2. Global Protein Degradation Therapy Revenue Market Share by Type in 2020
Figure 3. ARV-110
Figure 4. ARV-471
Figure 5. Other
Figure 6. Protein Degradation Therapy Revenue Market Share by Application in 2020
Figure 7. Cancer Picture
Figure 8. Neuroscience Picture
Figure 9. Other Picture
Figure 10. Global Protein Degradation Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Protein Degradation Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Protein Degradation Therapy Revenue Market Share by Region (2016-2026)
Figure 13. Global Protein Degradation Therapy Revenue Market Share by Region in 2020
Figure 14. North America Protein Degradation Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Protein Degradation Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Protein Degradation Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Protein Degradation Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Protein Degradation Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Protein Degradation Therapy Market Drivers
Figure 20. Protein Degradation Therapy Market Restraints
Figure 21. Protein Degradation Therapy Market Trends
Figure 22. Arvinas Recent Developments and Future Plans
Figure 23. Nurix Therapeutics Recent Developments and Future Plans
Figure 24. Kymera Therapeutics Recent Developments and Future Plans
Figure 25. C4 Therapeutics Recent Developments and Future Plans
Figure 26. Global Protein Degradation Therapy Revenue Share by Players in 2020
Figure 27. Protein Degradation Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 28. Global Top 3 Players Protein Degradation Therapy Revenue Market Share in 2020
Figure 29. Global Top 10 Players Protein Degradation Therapy Revenue Market Share in 2020
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 31. Global Protein Degradation Therapy Revenue Share by Type in 2020
Figure 32. Global Protein Degradation Therapy Market Share Forecast by Type (2021-2026)
Figure 33. Global Protein Degradation Therapy Revenue Share by Application in 2020
Figure 34. Global Protein Degradation Therapy Market Share Forecast by Application (2021-2026)
Figure 35. North America Protein Degradation Therapy Sales Market Share by Type (2016-2026)
Figure 36. North America Protein Degradation Therapy Sales Market Share by Application (2016-2026)
Figure 37. North America Protein Degradation Therapy Revenue Market Share by Country (2016-2026)
Figure 38. United States Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Canada Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Mexico Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Europe Protein Degradation Therapy Sales Market Share by Type (2016-2026)
Figure 42. Europe Protein Degradation Therapy Sales Market Share by Application (2016-2026)
Figure 43. Europe Protein Degradation Therapy Revenue Market Share by Country (2016-2026)
Figure 44. Germany Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. France Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. United Kingdom Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Russia Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Italy Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Protein Degradation Therapy Sales Market Share by Type (2016-2026)
Figure 50. Asia-Pacific Protein Degradation Therapy Sales Market Share by Application (2016-2026)
Figure 51. Asia-Pacific Protein Degradation Therapy Revenue Market Share by Region (2016-2026)
Figure 52. China Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Japan Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. South Korea Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. India Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Southeast Asia Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Australia Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South America Protein Degradation Therapy Sales Market Share by Type (2016-2026)
Figure 59. South America Protein Degradation Therapy Sales Market Share by Application (2016-2026)
Figure 60. South America Protein Degradation Therapy Revenue Market Share by Country (2016-2026)
Figure 61. Brazil Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Argentina Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Middle East and Africa Protein Degradation Therapy Sales Market Share by Type (2016-2026)
Figure 64. Middle East and Africa Protein Degradation Therapy Sales Market Share by Application (2016-2026)
Figure 65. Middle East and Africa Protein Degradation Therapy Revenue Market Share by Country (2016-2026)
Figure 66. Turkey Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Saudi Arabia Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. UAE Protein Degradation Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source

Table of Contents

Related reports :

(Sep 21)

The Pacemakers and Cardiac Resynchronization Therapy Devices market report provides a detailed analysis of global market size, regional and ...

(Sep 21)

The Rapid Influenza Diagnostic Test (RIDT) market report provides a detailed analysis of global market size, regional and country-level mark...

(Sep 21)

The Soliris (Eculizumab) market report provides a detailed analysis of global market size, regional and country-level market size, segmentat...

(Sep 21)

The Rosacea Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentatio...

(Sep 21)

The Prosthetic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market...

(Sep 21)

The Central Venous Access Devices market report provides a detailed analysis of global market size, regional and country-level market size, ...

Global Info Research

GLOBAL PROTEIN DEGRADATION THERAPY MARKET 2021 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy